RenaissanceRe reported a net loss attributable to common shareholders of $82.0 million, or $1.89 per diluted common share, in the first quarter of 2020. The financial performance was negatively impacted by COVID-19 and investment losses, but the company remains well capitalized with ample liquidity.
Net loss attributable to RenaissanceRe common shareholders was $82.0 million, or $1.89 per diluted common share.
Operating income available to common shareholders was $33.4 million, or $0.76 per diluted common share.
Gross premiums written increased by $461.4 million, or 29.5%, to $2.0 billion.
The Casualty and Specialty segment incurred an underwriting loss of $83.2 million, impacted by COVID-19 related claims.
RenaissanceRe is continuing to evaluate the impact of COVID-19 on its business and to estimate all of the Company’s potential reinsurance, insurance or investment exposures, or any other effects that the COVID-19 pandemic may have on its results of operations or financial condition. The Company expects losses to emerge over time as the full impact of the pandemic and its effects on the global economy are realized.